Farmacología y Toxicología
Departamento
Imperial College London
Londres, Reino UnidoPublicacións en colaboración con investigadores/as de Imperial College London (30)
2021
-
Impact of COVID-19 on vascular patients worldwide: Analysis of the COVIDSurg data
Journal of Cardiovascular Surgery, Vol. 62, Núm. 6, pp. 558-570
-
Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention
International Journal of Cardiology, Vol. 337, pp. 1-8
2019
-
Preventing bronchopulmonary dysplasia: new tools for an old challenge
Pediatric Research, Vol. 85, Núm. 4, pp. 432-441
2017
-
Chemical and biological assessment of metal organic frameworks (MOFs) in pulmonary cells and in an acute in vivo model: relevance to pulmonary arterial hypertension therapy
Pulmonary Circulation, Vol. 7, Núm. 3, pp. 643-653
2016
-
In Vivo Assessment of Metal Organic Framework (MOFs) for the Future use as Delivery Agents for Drugs to Treat PAH
World Congress on Recent Advances in Nanotechnology
-
In vivo assessment of metal organic framework (MOFs) for the future use as delivery agents for drugs to treat PAH
World Congress on Recent Advances in Nanotechnology
2015
-
An entangled model for sustainability indicators
PLoS ONE, Vol. 10, Núm. 8
2013
-
A simple whole blood bioassay detects cytokine responses to anti-CD28SA and anti-CD52 antibodies
Journal of Pharmacological and Toxicological Methods, Vol. 68, Núm. 2, pp. 231-239
-
Therapeutic targeting of NOD1 receptors
British Journal of Pharmacology, Vol. 170, Núm. 3, pp. 475-485
2012
-
A key role for the endothelium in NOD1 mediated vascular inflammation: Comparison to TLR4 responses
PLoS ONE, Vol. 7, Núm. 8
2010
-
Innate immunity in human embryonic stem cells: Comparison with adult human endothelial cells
PLoS ONE, Vol. 5, Núm. 5
-
Nucleotide oligomerization domain 1 is a dominant pathway for NOS2 induction in vascular smooth muscle cells: Comparison with Toll-like receptor 4 responses in macrophages
British Journal of Pharmacology, Vol. 160, Núm. 8, pp. 1997-2007
-
The PPARβ/δagonist GW0742 relaxes pulmonary vessels and limits right heart hypertrophy in rats with hypoxia-induced pulmonary hypertension
PLoS ONE, Vol. 5, Núm. 3
2009
-
Toll-like receptor 2 is essential for the sensing of oxidants during inflammation
American Journal of Respiratory and Critical Care Medicine, Vol. 179, Núm. 4, pp. 299-306
2008
-
Aliskiren - The first of a new class of antihypertensive
Drugs in Context, Vol. 4, Núm. 1, pp. 105-120
-
COX-1, and not COX-2 activity, regulates airway function: Relevance to aspirin-sensitive asthma
FASEB Journal, Vol. 22, Núm. 11, pp. 4005-4010
-
Cervarix - Preventing cervical cancer and other diseases related to HPV
Drugs in Context, Vol. 4, Núm. 1, pp. 59-70
-
Coversyl Plus - Treating hypertension and improving clinical outcomes in T2D and other high risk groups
Drugs in Context, Vol. 4, Núm. 1, pp. 71-84
-
Ezetimibe - A clinically effective and a cost-effective treatment option for dyslipidaemia
Drugs in Context, Vol. 4, Núm. 1, pp. 85-104
-
Gardasil - Preventing cervical cancer and other diseases related to HPV
Drugs in Context, Vol. 4, Núm. 1, pp. 29-40